Evidence map›Paper›PMID 38884814›Full record

ArticleCellular and molecular life sciences : CMLS2024

Glycine-induced activation of GPR158 increases the intrinsic excitability of medium spiny neurons in the nucleus accumbens.

Giuseppe Aceto, Luca Nardella, Simona Nanni, Valeria Pecci, Alessia Bertozzi, Sofia Nutarelli, Maria Teresa Viscomi, Claudia Colussi, Marcello D'Ascenzo, Claudio Grassi

Registry-linked trialAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07732933 (GSK-3 as a Target for Lithium-charged Au Nanoparticles in Bipolar Disorder), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07732933 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

GSK-3 as a Target for Lithium-charged Au Nanoparticles in Bipolar Disorder

TypeinterventionalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2026 to 2029Enrolled20ConditionsBipolar Disorder (BD), Bipolar Disorder (BPD)ArmsPeripheral blood sampling for PBMC isolation
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. NAR molecular medicine · 2026
    Article
  6. Review
  7. Article
  8. Osteocalcin and GPR158: linking bone and brain function.Frontiers in cell and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Giuseppe AcetoFondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy.
Luca NardellaDepartment of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Simona NanniFondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy.
Valeria PecciDepartment of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Alessia BertozziDepartment of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Sofia NutarelliDepartment of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Maria Teresa ViscomiDepartment of Life Science and Public Health, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Claudia ColussiFondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy.
Marcello D'Ascenzo *Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy. marcello.dascenzo@unicatt.it.ORCID http://orcid.org/0000-0003-0073-412X
Claudio Grassi *Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, 00168, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been recently established that GPR158, a class C orphan G protein-coupled receptor, serves as a metabotropic glycine receptor. GPR158 is highly expressed in the nucleus accumbens (NAc), a major input structure of the basal ganglia that integrates information from cortical and subcortical structures to mediate goal-directed behaviors. However, whether glycine modulates neuronal activity in the NAc through GPR158 activation has not been investigated yet. Using whole-cell patch-clamp recordings, we found that glycine-dependent activation of GPR158 increased the firing rate of NAc medium spiny neurons (MSNs) while it failed to significantly affect the excitability of cholinergic interneurons (CIN). In MSNs GPR158 activation reduced the latency to fire, increased the action potential half-width, and reduced action potential afterhyperpolarization, effects that are all consistent with negative modulation of potassium M-currents, that in the central nervous system are mainly carried out by Kv7/KCNQ-channels. Indeed, we found that the GPR158-induced increase in MSN excitability was associated with decreased M-current amplitude, and selective pharmacological inhibition of the M-current mimicked and occluded the effects of GPR158 activation. In addition, when the protein kinase A (PKA) or extracellular signal-regulated kinase (ERK) signaling was pharmacologically blocked, modulation of MSN excitability by GPR158 activation was suppressed. Moreover, GPR158 activation increased the phosphorylation of ERK and Kv7.2 serine residues. Collectively, our findings suggest that GPR158/PKA/ERK signaling controls MSN excitability via Kv7.2 modulation. Glycine-dependent activation of GPR158 may significantly affect MSN firing in vivo, thus potentially mediating specific aspects of goal-induced behaviors.

Indexed as

Action PotentialsGlycineNeuronsNucleus AccumbensReceptors, G-Protein-CoupledAnimalsMaleMedium Spiny NeuronsMiceMice, Inbred C57BLPatch-Clamp TechniquesPhosphorylationReceptors, GlycineGlycineReceptors, GlycineReceptors, G-Protein-CoupledGlycineGPR158Intrinsic excitabilityM-currentMedium spiny neuronsMetabotropic glycine receptor

Identifiers

PMID38884814
PMCPMC11335193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.